✦ LIBER ✦

Pharmacokinetics of milnacipran in renal impairment

✍ Scribed by C. Puozzo; N. Pozet; D. Deprez; P. Baille; H. L. Ung; P. Zech P

Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 927 KB
Volume: 23
Category: Article
ISSN: 0378-7966
DOI: 10.1007/bf03189352

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of amlodipine in renal

Pharmacokinetics of amlodipine in renal impairment

✍ G. D. Doyle; J. Donohue; M. Carmody; M. Laher; H. Greb; M. Volz 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 322 KB

Pharmacokinetics of atenolol in patients

Pharmacokinetics of atenolol in patients with renal impairment

✍ J. Sassard; N. Pozet; J. McAinsh; J. Legheand; P. Zech 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 660 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment

✍ K. M. Koch; M. Liu; I. M. Davis; S. Shaw; Y. Yin 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 205 KB

Pharmacokinetics of oral acetyl-L-carnit

Pharmacokinetics of oral acetyl-L-carnitine in renal impairment

✍ J. G. Kelly; S. Hunt; G. D. Doyle; M. S. Laher; M. Carmody; A. Marzo; E. Arrigon 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 350 KB

Acetyl-L-carnitine 1.5 g and 3.0 g was administered as three divided doses on each of two occasions to 24 people with varying renal failure (creatinine clearance 127-8 ml.min-1). Plasma and urinary concentrations of total-L-carnitine, free (non-esterified) carnitine, short-chain esters and acetyl-L-

Pharmacokinetics of carteolol in patient

Pharmacokinetics of carteolol in patients with impaired renal function

✍ M. Amemiya; K. Tabei; H. Furuya; Y. Sakairi; Y. Asano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 503 KB

Pharmacokinetics of tenoxicam in patient

Pharmacokinetics of tenoxicam in patients with impaired renal function

✍ F. F. Horber; T. W. Guentert; E. Weidekamm; P. Heizmann; C. Descoeudres; F. J. F 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 505 KB